This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Prion
From Proteopedia
(Difference between revisions)
| Line 13: | Line 13: | ||
Here we use molecular dynamics simulations to investigate the structural determinants of the globular domain in engineered Mouse (Mo) PrP variants, in WT human (Hu) PrP (PDB: [[1hjn]]) and in WT MoPrP (PDB: [[1xyx]]). The Mo PrP variants investigated here contain one or two residues from ''Homo sapiens'' and are denoted “MoPrP chimeras”. <scene name='Journal:JBSD:4/Cv/3'>Some of them are resistant to PrP<sup>Sc</sup> infection</scene> <span style="color:yellow;background-color:black;font-weight:bold;">(colored in yellow)</span> in ''in vivo'' or in ''in vitro'' cell-culture experiments, the <scene name='Journal:JBSD:4/Cv/7'>others are not</scene> <font color='darkmagenta'><b>(in darkmagenta)</b></font>. Our main results are the following: (i) The chimeras resistant to PrP<sup>Sc</sup> infection show <scene name='Journal:JBSD:4/Cv/8'>shorter intramolecular distances</scene> between the α1 helix and N-terminal of α3 helix than HuPrP, MoPrP and the non-resistant chimeras (<scene name='Journal:JBSD:4/Cv/12'>click here to see morph</scene>). This is due to stronger specific interactions between these two regions, mainly the <scene name='Journal:JBSD:4/Cv/9'>Y149-D202 and D202-Y157 (in Hu numbering and hereafter) hydrogen bonds</scene> and the <scene name='Journal:JBSD:4/Cv/10'>R156-E196 salt bridge</scene>. (ii) The β2-α2 <scene name='Journal:JBSD:4/Cv1/2'>loop (residues 167-171)</scene> of PrP<sup>C</sup> is known to differ in its conformation across different species and is suggested to be responsible for the species barrier of PrP<sup>Sc</sup> propagation. Our simulations detect exchanges between different conformations in this loop which can be categorized into two distinct patterns: some chimeras experience a 3<sub>10</sub>-helix/turn pattern like in MoPrP and others show a bend/turn pattern like in HuPrP. In the <span style="color:lime;background-color:black;font-weight:bold;">Mo-like pattern (colored in green)</span>, 3<sub>10</sub>-helix conformation is stabilized by the <scene name='Journal:JBSD:4/Cv1/3'>Q168-P165 and Y169-V166 hydrogen bonds</scene>. In the <font color='darkred'><b>Hu-like pattern (colored in darkred)</b></font>, a <scene name='Journal:JBSD:4/Cv1/4'>D167-S170 hydrogen bond</scene> stabilizes the bend conformation. Interestingly, the dominant-negative effect of MoPrP chimeras over WT MoPrP occurs if the chimera not only resists PrP<sup>Sc</sup> infection but also adopts the Mo-like pattern of exchanges between conformations in the β2-α2 loop. This suggests that the compatible loop conformation allows these dominant-negative chimeras to interfere with the conversion of MoPrP to PrP<sup>Sc</sup>. | Here we use molecular dynamics simulations to investigate the structural determinants of the globular domain in engineered Mouse (Mo) PrP variants, in WT human (Hu) PrP (PDB: [[1hjn]]) and in WT MoPrP (PDB: [[1xyx]]). The Mo PrP variants investigated here contain one or two residues from ''Homo sapiens'' and are denoted “MoPrP chimeras”. <scene name='Journal:JBSD:4/Cv/3'>Some of them are resistant to PrP<sup>Sc</sup> infection</scene> <span style="color:yellow;background-color:black;font-weight:bold;">(colored in yellow)</span> in ''in vivo'' or in ''in vitro'' cell-culture experiments, the <scene name='Journal:JBSD:4/Cv/7'>others are not</scene> <font color='darkmagenta'><b>(in darkmagenta)</b></font>. Our main results are the following: (i) The chimeras resistant to PrP<sup>Sc</sup> infection show <scene name='Journal:JBSD:4/Cv/8'>shorter intramolecular distances</scene> between the α1 helix and N-terminal of α3 helix than HuPrP, MoPrP and the non-resistant chimeras (<scene name='Journal:JBSD:4/Cv/12'>click here to see morph</scene>). This is due to stronger specific interactions between these two regions, mainly the <scene name='Journal:JBSD:4/Cv/9'>Y149-D202 and D202-Y157 (in Hu numbering and hereafter) hydrogen bonds</scene> and the <scene name='Journal:JBSD:4/Cv/10'>R156-E196 salt bridge</scene>. (ii) The β2-α2 <scene name='Journal:JBSD:4/Cv1/2'>loop (residues 167-171)</scene> of PrP<sup>C</sup> is known to differ in its conformation across different species and is suggested to be responsible for the species barrier of PrP<sup>Sc</sup> propagation. Our simulations detect exchanges between different conformations in this loop which can be categorized into two distinct patterns: some chimeras experience a 3<sub>10</sub>-helix/turn pattern like in MoPrP and others show a bend/turn pattern like in HuPrP. In the <span style="color:lime;background-color:black;font-weight:bold;">Mo-like pattern (colored in green)</span>, 3<sub>10</sub>-helix conformation is stabilized by the <scene name='Journal:JBSD:4/Cv1/3'>Q168-P165 and Y169-V166 hydrogen bonds</scene>. In the <font color='darkred'><b>Hu-like pattern (colored in darkred)</b></font>, a <scene name='Journal:JBSD:4/Cv1/4'>D167-S170 hydrogen bond</scene> stabilizes the bend conformation. Interestingly, the dominant-negative effect of MoPrP chimeras over WT MoPrP occurs if the chimera not only resists PrP<sup>Sc</sup> infection but also adopts the Mo-like pattern of exchanges between conformations in the β2-α2 loop. This suggests that the compatible loop conformation allows these dominant-negative chimeras to interfere with the conversion of MoPrP to PrP<sup>Sc</sup>. | ||
The structural features presented here indicate that stronger interactions between α1 helix and N-terminal of α3 helix are related to the resistance to PrP<sup>C</sup> → PrP<sup>Sc</sup> conversion, while the β2-α2 loop conformation may play an important role in the dominant-negative effect. | The structural features presented here indicate that stronger interactions between α1 helix and N-terminal of α3 helix are related to the resistance to PrP<sup>C</sup> → PrP<sup>Sc</sup> conversion, while the β2-α2 loop conformation may play an important role in the dominant-negative effect. | ||
| + | |||
| + | ==3D structures of prion== | ||
| + | [[Prion 3D structures ]] | ||
| + | |||
</StructureSection> | </StructureSection> | ||
| Line 22: | Line 26: | ||
*Prion short polypeptides | *Prion short polypeptides | ||
| - | **[[3nve]] – ShPrP residues 138 -143 – Syrian hamster<br /> | ||
| - | **[[2kkg]] - GhPrP residues 23 -106 – Golden hamster - NMR<br /> | ||
**[[3nvf]] – hPrP residues 138 -143 – human<br /> | **[[3nvf]] – hPrP residues 138 -143 – human<br /> | ||
**[[2ol9]] - hPrP residues 170 – 175<br /> | **[[2ol9]] - hPrP residues 170 – 175<br /> | ||
| Line 34: | Line 36: | ||
**[[2iv4]] - hPrP residues 180 -195 – NMR<br /> | **[[2iv4]] - hPrP residues 180 -195 – NMR<br /> | ||
**[[4e1h]], [[4e1i]] - hPrP residues 177 -182 + 211-216<br /> | **[[4e1h]], [[4e1i]] - hPrP residues 177 -182 + 211-216<br /> | ||
| - | **[[3nvg]], [[3nvh]] - mPrP residues 138 -143 – mouse<br /> | ||
**[[1skh]] - bPrP residues 1 – 30 - bovine<br /> | **[[1skh]] - bPrP residues 1 – 30 - bovine<br /> | ||
**[[3fva]] - ePrP residues 173 -178 – Elk<br /> | **[[3fva]] - ePrP residues 173 -178 – Elk<br /> | ||
| Line 42: | Line 43: | ||
**[[2rmv]], [[2rmw]] - sPrP residues 142 – 166 (mutant) – NMR<br /> | **[[2rmv]], [[2rmw]] - sPrP residues 142 – 166 (mutant) – NMR<br /> | ||
**[[6axz]], [[6btk]] - vPrP residues 168 - 176 – vole<br /> | **[[6axz]], [[6btk]] - vPrP residues 168 - 176 – vole<br /> | ||
| + | **[[3nve]] – ShPrP residues 138 -143 – Syrian hamster<br /> | ||
| + | **[[2kkg]] - GhPrP residues 23 -106 – Golden hamster - NMR<br /> | ||
| + | **[[3nvg]], [[3nvh]] - mPrP residues 138 -143 – mouse<br /> | ||
*Prion | *Prion | ||
| + | **[[3haf]], [[3hak]], [[3hj5]], [[1i4m]] - hPrP C-terminal<br /> | ||
| + | **[[1hjm]], [[1hjn]], [[2kun]], [[5l6r]], [[5yj5]] – hPrP C-terminal – NMR<br /> | ||
| + | **[[1h0l]], [[1fkc]], [[2k1d]], [[1fo7]], [[1e1s]], [[1e1g]], [[1e1j]], [[1e1p]], [[1e1u]], [[1e1w]], [[1qlx]], [[1qlz]], [[1qm0]], [[1qm1]], [[1qm2]], [[1qm3]], [[1qlz]], [[1qm0]], [[1qm1]], [[2lej]], [[5yj4]] - hPrP C-terminal (mutant) - NMR<br /> | ||
| + | **[[3heq]], [[3her]], [[3hes]], [[3hjx]] - hPrP C-terminal (mutant)<br /> | ||
| + | **[[2lft]], [[2lsb]], [[2m8t]] - hPrP residues 90 -231 – NMR<br /> | ||
| + | **[[2lv1]] - hPrP residues 90 -231 (mutant) – NMR<br /> | ||
| + | **[[2lsb]] - hPrP residues 120 -230 + antibody<br /> | ||
**[[3o79]] – rPrP C-terminal – rabbit<br /> | **[[3o79]] – rPrP C-terminal – rabbit<br /> | ||
**[[4hls]], [[4hmm]], [[4hmr]]- rPrP C-terminal (mutant)<br /> | **[[4hls]], [[4hmm]], [[4hmr]]- rPrP C-terminal (mutant)<br /> | ||
**[[2fj3]] - rPrP C-terminal – NMR<br /> | **[[2fj3]] - rPrP C-terminal – NMR<br /> | ||
**[[2joh]], [[2jom]] - rPrP C-terminal (mutant) – NMR<br /> | **[[2joh]], [[2jom]] - rPrP C-terminal (mutant) – NMR<br /> | ||
| - | **[[1xyw]] – ePrP C terminal - NMR<br /> | + | **[[1xyw]], [[3fva]] – ePrP C terminal - NMR<br /> |
**[[2ku4]] - PrP C-terminal – horse<br /> | **[[2ku4]] - PrP C-terminal – horse<br /> | ||
| - | **[[3fva]] - ePrP C-terminal – NMR<br /> | ||
**[[2kfl]] - PrP C-terminal – Wallaby – NMR<br /> | **[[2kfl]] - PrP C-terminal – Wallaby – NMR<br /> | ||
| - | **[[2k56]] - PrP C-terminal – Vole – NMR<br /> | ||
**[[2ktm]] – sPrP residues 167-234 H2H3 domain (mutant) – NMR<br /> | **[[2ktm]] – sPrP residues 167-234 H2H3 domain (mutant) – NMR<br /> | ||
**[[1xyu]], [[1y2s]], [[2n53]] - sPrP C-terminal – NMR<br /> | **[[1xyu]], [[1y2s]], [[2n53]] - sPrP C-terminal – NMR<br /> | ||
**[[2mv8]], [[2mv9]] - sPrP C-terminal (mutant) – NMR<br /> | **[[2mv8]], [[2mv9]] - sPrP C-terminal (mutant) – NMR<br /> | ||
**[[1uw3]] - sPrP C-terminal<br /> | **[[1uw3]] - sPrP C-terminal<br /> | ||
| - | **[[3haf]], [[3hak]], [[3hj5]], [[1i4m]] - hPrP C-terminal<br /> | ||
| - | **[[1hjm]], [[1hjn]], [[2kun]], [[5l6r]], [[5yj5]] – hPrP C-terminal – NMR<br /> | ||
| - | **[[1h0l]], [[1fkc]], [[2k1d]], [[1fo7]], [[1e1s]], [[1e1g]], [[1e1j]], [[1e1p]], [[1e1u]], [[1e1w]], [[1qlx]], [[1qlz]], [[1qm0]], [[1qm1]], [[1qm2]], [[1qm3]], [[1qlz]], [[1qm0]], [[1qm1]], [[2lej]], [[5yj4]] - hPrP C-terminal (mutant) - NMR<br /> | ||
| - | **[[3heq]], [[3her]], [[3hes]], [[3hjx]] - hPrP C-terminal (mutant)<br /> | ||
| - | **[[2lft]], [[2lsb]], [[2m8t]] - hPrP residues 90 -231 – NMR<br /> | ||
| - | **[[2lv1]] - hPrP residues 90 -231 (mutant) – NMR<br /> | ||
| - | **[[2lsb]] - hPrP residues 120 -230 + antibody<br /> | ||
| - | **[[2ku5]], [[2ku6]], [[2kfm]], [[2kfo]], [[2k5o]], [[1y16]], [[1y15]] - mPrP C-terminal (mutant) - NMR<br /> | ||
| - | **[[1xyx]] - mPrP C-terminal - NMR<br /> | ||
| - | **[[2l1k]], [[2l1d]], [[2l1e]], [[2l40]] - mPrP C terminal (mutant) – NMR<br /> | ||
| - | **[[1ag2]], [[2l1h]], [[2l39]] - mPrP C terminal - NMR<br /> | ||
**[[1u3m]] – PrP C-terminal – chicken – NMR<br /> | **[[1u3m]] – PrP C-terminal – chicken – NMR<br /> | ||
**[[1u5l]] - PrP C-terminal – turtle – NMR<br /> | **[[1u5l]] - PrP C-terminal – turtle – NMR<br /> | ||
| Line 78: | Line 76: | ||
**[[1dwz]] - bPrP C-terminal (mutant) - NMR<br /> | **[[1dwz]] - bPrP C-terminal (mutant) - NMR<br /> | ||
**[[1b10]] - ShPrP C-terminal – NMR<br /> | **[[1b10]] - ShPrP C-terminal – NMR<br /> | ||
| - | **[[2lh8]] - ShPrP C-terminal + thiamine – NMR | + | **[[2lh8]] - ShPrP C-terminal + thiamine – NMR<br /> |
| + | **[[2k56]] - PrP C-terminal – Vole – NMR<br /> | ||
| + | **[[2ku5]], [[2ku6]], [[2kfm]], [[2kfo]], [[2k5o]], [[1y16]], [[1y15]] - mPrP C-terminal (mutant) - NMR<br /> | ||
| + | **[[1xyx]] - mPrP C-terminal - NMR<br /> | ||
| + | **[[2l1k]], [[2l1d]], [[2l1e]], [[2l40]] - mPrP C terminal (mutant) – NMR<br /> | ||
*Yeast prions | *Yeast prions | ||
| Line 91: | Line 93: | ||
**[[2w9e]], [[4h88]], [[2lsb]], [[4dgi]], [[6aq7]] - hPrP C-terminal + anti-PrP antibody<br /> | **[[2w9e]], [[4h88]], [[2lsb]], [[4dgi]], [[6aq7]] - hPrP C-terminal + anti-PrP antibody<br /> | ||
| - | **[[4j8r]] - mPrP residues 67-82 + antibody<br /> | ||
| - | **[[4ma7]], [[4ma8]] - mPrP residues 116 - 229 + antibody<br /> | ||
**[[4n9o]] - hPrP C terminal + nanobody<br /> | **[[4n9o]] - hPrP C terminal + nanobody<br /> | ||
**[[4kml]] - hPrP + nanobody<br /> | **[[4kml]] - hPrP + nanobody<br /> | ||
**[[2hh0]] - bPrP peptide epitope + anti-PrP antibody<br /> | **[[2hh0]] - bPrP peptide epitope + anti-PrP antibody<br /> | ||
| - | **[[ | + | **[[4yx2]] - bPrP + antibody<br /> |
**[[1tpx]], [[1tqb]], [[1tqc]] - sPrP C-terminal + anti-PrP antibody<br /> | **[[1tpx]], [[1tqb]], [[1tqc]] - sPrP C-terminal + anti-PrP antibody<br /> | ||
| - | **[[4yx2]] - bPrP + antibody<br /> | ||
**[[4yxh]] - PrP + antibody – mule deer<br /> | **[[4yxh]] - PrP + antibody – mule deer<br /> | ||
| - | **[[4yxk]] - | + | **[[4yxk]] - ePrP + antibody <br /> |
**[[4yxl]] - GhPrP + antibody<br /> | **[[4yxl]] - GhPrP + antibody<br /> | ||
| + | **[[4j8r]] - mPrP residues 67-82 + antibody<br /> | ||
| + | **[[4ma7]], [[4ma8]] - mPrP residues 116 - 229 + antibody<br /> | ||
| + | **[[1cu4]] - ShPrP peptide epitope + anti-PrP antibody<br /> | ||
*HET-S from ''Podospora anserine'' | *HET-S from ''Podospora anserine'' | ||
| Line 110: | Line 112: | ||
}} | }} | ||
<references/> | <references/> | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Revision as of 09:45, 27 November 2019
| |||||||||||
3D structures of prion
Updated on 27-November-2019
- ↑ Cong X, Bongarzone S, Giachin G, Rossetti G, Carloni P, Legname G. Dominant-negative effects in prion diseases: insights from molecular dynamics simulations on mouse prion protein chimeras. J Biomol Struct Dyn. 2012 Aug 30. PMID:22934595 doi:10.1080/07391102.2012.712477

